OTC · RTGN
RetinalGenix Technologies Inc.
$3.99$0.00 (0.0%)
RetinalGenix Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 20.52% below the high.
Loading market information…
OTC · EEOIF · USD
Stock price
Quote as of May 25, 2022, 02:40 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Elegance Optical International Holdings Limited’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Elegance Optical International Holdings Limited operates as an investment holding company with a primary focus on the global manufacturing and distribution of optical frames and sunglasses. The company maintains a significant market presence across Europe, the United States, mainland China, other Asian regions, and various international territories. Its diverse business portfolio is structured into several key segments: Manufacturing and Trading (centered on optical goods), Property Investment (which includes leasing activities), Debts and Securities Investment (managing financial instruments and publicly traded shares), Film Investment and Distribution (covering film rights and movie-related ventures), and an Energy Business (involving sector investments and the sale and trading of liquefied petroleum gas products). Furthermore, the company engages in money lending and the trading of bags. Formerly known as Elegance International Holdings Limited, the firm adopted its current name in September 2013. Its corporate headquarters are located in Wan Chai, Hong Kong.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:23 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$3.99$0.00 (0.0%)
RetinalGenix Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 20.52% below the high.
$1.00$0.00 (0.0%)
Taihe Group, Inc.’s quoted price sits in the lower half of its reported 52-week range, 69.7% below the high.
$0.66-$3.84 (-85.33%)
Biocartis Group N.V.: Healthcare · Medical - Diagnostics & Research.
SEK 1.67-SEK 0.04 (-2.22%)
Oncopeptides AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 72.75% below the high.
$0.45$0.00 (0.0%)
Goodness Growth Holdings, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$4.03+$0.03 (+0.75%)
Biostage, Inc.’s quoted price sits in the lower half of its reported 52-week range, 55.22% below the high.
$0.55-$0.01 (-1.1%)
MCI Onehealth Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.47% below the high.
€1.18-€0.02 (-1.67%)
Herantis Pharma Oyj’s quoted price sits in the lower half of its reported 52-week range, 58.89% below the high.
